Venous Thromboembolism Risk Lower among Patients with atopic dermatitis

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-01-01 00:30 GMT   |   Update On 2024-01-01 00:30 GMT
Advertisement

Venous thromboembolism risk is lower among atopic dermatitis patients versus other immune-mediated inflammatory diseases suggests a new study published in the Journal of the American Academy of Dermatology.

Certain immune-mediated inflammatory diseases (IMIDs) may increase patients’ risk for venous thromboembolisms (VTEs), yet how atopic dermatitis (AD) influences VTE risk remains unclear. Describe venous thromboembolism incidence in patients with atopic dermatitis compared with other IMIDs and unaffected, atopic dermatitis-matched controls. This retrospective, observational, comparative cohort study used Optum® Clinformatics® United States claims data (2010–2019) of adults with atopic dermatitis, rheumatoid arthritis (RA), Crohn’s disease (CD), ulcerative colitis (UC), psoriasis (PsO), psoriatic arthritis (PsA), or ankylosing spondylitis (AS). Unaffected control patients were matched 1:1 with patients with atopic dermatitis. Results: Of 2,061,222 patients with IMIDs, 1,098,633 had atopic dermatitis. Patients with atopic dermatitis had a higher venous thromboembolism incidence (95% CI) than unaffected, atopic dermatitis-matched controls. However, when controlling for baseline VTE risk factors, atopic dermatitis was not associated with increased venous thromboembolism risk. Venous thromboembolism risk was lower in patients with atopic dermatitis versus RA, UC, CD, AS, or PsA; venous thromboembolism risk was similar in patients with psoriasis. atopic dermatitis did not increase venous thromboembolism risk when accounting for underlying risk factors. Atopic dermatitis was associated with lower venous thromboembolism risk compared with several rheumatologic and gastrointestinal IMIDs.

Advertisement
Reference: Joseph F. Merola, Brennan Ertmer, Huifang Liang, Xiaomeng Yue, Sarah Ofori, Whitney Krueger. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data, Journal of the American Academy of Dermatology, 2023, ISSN 0190-9622. https://doi.org/10.1016/j.jaad.2023.12.027.

(https://www.sciencedirect.com/science/article/pii/S019096222303400X)

Keywords: VTE, risk, lower, among, atopic, dermatitis, patients, versus, other, immune-mediated, inflammatory, diseases, Journal of the American Academy of Dermatology, Joseph F. Merola, Brennan Ertmer, Huifang Liang, Xiaomeng Yue, Sarah Ofori, Whitney Krueger, atopic dermatitis; cohort study; immune-mediated inflammatory disease; observational study; vascular disease; venous thromboembolism
Tags:    
Article Source : Journal of the American Academy of Dermatology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News